Krum, Henry (Personal Name)

Heart failure, c2007: E-CIP t.p. (Henry Krum, MBBS, Ph. D., FRACP, prof. and dir., NHMRC, CCRE in Therapeutics, Depts. of Epidemiology & Preventive Medicine, Monash Univ./Alfred Hosp., Melbourne, Vic., Australia)

Monash University, News and events, 'Vale Henry Krum', 9 December 2015; viewed April 21, 2016: (Professor Krum was with the School of Public Health and Preventive Medicine, and one of the finest cardiovascular researchers and specialists in heart failure management in the world. He joined Monash University in 1996 and was appointed Head of the Clinical Pharmacology Unit in the Department of Epidemiology and Preventive Medicine and Head of the Clinical Pharmacology Department at the Alfred Hospital. He ranked first for the most citations and third for the highest number of publications from all Monash University researchers, in the 2010-2014 period. Over his career he published over 500 journal articles, 4 books and 22 book chapters. He was a member of the Executive Committee that established the value of beta-blockers in severe heart failure. He was the first author of a paper in the Journal of the American Medical Association that described for the first time, the finding that beta-blockers may produce an early beneficial effect on clinical outcomes) http://monash.edu/news/show/vale-henry-krum

Monash University, School of Public Health and Preventive Medicine blog, Tuesday, 8 December 2015, 'Henry Krum, 1958-2015'; viewed April 21, 2016: (Professor Henry Krum was credited with putting Australia on the map with respect to clinical trials in cardiovascular disease, particularly in chronic heart disease. He also made the 2015 Thomson Reuters Highly Cited Researcher list, ranking him as one of the world's most influential scientific minds, and in the top one per cent most cited in his subject field this year. Henry was internationally noted for his leadership in novel cardiovascular drug treatments. He was also involved in a number of definitive studies of beta-blockade which have become a cornerstone of heart failure management and his leadership in the development of guidelines had a major influence on the field. It is estimated that Henry conducted approximately 150 individual clinical trials over his career. Henry was the recipient of countless awards and accolades within his field. He also sat on many international steering committees and was a principal investigator on a number of international collaborative studies and was one of the leading heart failure researchers in the world. He undertook the roles of editor, associate editor and/or on the editorial board of many international journals) http://sphpm.blogspot.com.au/2015/12/henry-krum-1958-2015.html